Prime Medicine (PRME) announced the appointment of Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer, CBO. Most recently, Hawryluk served as Chief Business Officer at AIRNA Corporation
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRME:
- Intellia Therapeutics price target lowered to $9 from $14 at Wedbush
- Prime Medicine price target raised to $5 from $4 at Citi
- PRME Earnings this Week: How Will it Perform?
- Cathie Wood Loads Up on Klarna, Synopsys, and Rubrik, Trims Shopify and Roblox Stocks
- Cathie Wood’s ARK Investment buys 231K shares of Prime Medicine today